Xanthine dehydrogenase

Xanthine dehydrogenase, also known as XDH, is a protein that, in humans, is encoded by the XDH gene.[5][6]

XDH
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesXDH, XO, XOR, xanthine dehydrogenase, XAN1
External IDsOMIM: 607633 MGI: 98973 HomoloGene: 324 GeneCards: XDH
Gene location (Human)
Chr.Chromosome 2 (human)[1]
Band2p23.1Start31,334,321 bp[1]
End31,414,742 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

7498

22436

Ensembl

ENSG00000158125

ENSMUSG00000024066

UniProt

P47989

Q00519

RefSeq (mRNA)

NM_000379

NM_011723

RefSeq (protein)

NP_000370

NP_035853

Location (UCSC)Chr 2: 31.33 – 31.41 MbChr 17: 73.88 – 73.95 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
xanthine dehydrogenase
Identifiers
EC number1.17.1.4
CAS number9054-84-6
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO

Function

Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The enzyme is a homodimer. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification.[5]

Xanthine dehydrogenase catalyzes the following chemical reaction:

xanthine + NAD+ + H2O urate + NADH + H+

The three substrates of this enzyme are xanthine, NAD+, and H2O, whereas its three products are urate, NADH, and H+.

This enzyme participates in purine metabolism.

Nomenclature

This enzyme belongs to the family of oxidoreductases, to be specific, those acting on CH or CH2 groups with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is xanthine:NAD+ oxidoreductase. Other names in common use include NAD+-xanthine dehydrogenase, xanthine-NAD+ oxidoreductase, xanthine/NAD+ oxidoreductase, and xanthine oxidoreductase.

Clinical significance

Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism.[5] It has been shown that patients with lung adenocarcinoma tumors which have high levels of XDH gene expression, have lower survivals.[7][8] Addiction to XDH protein has been used to target NSCLC tumors and cell lines in a precision oncology manner.[8]

gollark: And you can have Γ-3 clearance without being a site director.
gollark: No, being a site director is hard work!
gollark: Hello!
gollark: Anyway, you need to constantly develop random software and stuff which might be useful, help with random tasks, help with potatOS, sort of thing.
gollark: You don't!

See also

References

  1. GRCh38: Ensembl release 89: ENSG00000158125 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000024066 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Entrez Gene: XDH xanthine dehydrogenase". Retrieved October 25, 2012.
  6. Ichida K, Amaya Y, Noda K, Minoshima S, Hosoya T, Sakai O, Shimizu N, Nishino T (November 1993). "Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene". Gene. 133 (2): 279–84. doi:10.1016/0378-1119(93)90652-J. PMID 8224915.
  7. Konno H, Minamiya Y, Saito H, Imai K, Kawaharada Y, Motoyama S, Ogawa J (October 2012). "Acquired xanthine dehydrogenase expression shortens survival in patients with resected adenocarcinoma of lung". Tumour Biology. 33 (5): 1727–32. doi:10.1007/s13277-012-0431-2. PMID 22678977.
  8. Tavassoly I, Hu Y, Zhao S, Mariottini C, Boran A, Chen Y, Li L, Tolentino RE, Jayaraman G, Goldfarb J, Gallo J, Iyengar R (May 2019). "Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses". Molecular Oncology. 13 (8): 1725–1743. doi:10.1002/1878-0261.12521. PMC 6670022. PMID 31116490.

Further reading

  • Overview of all the structural information available in the PDB for UniProt: P47989 (Xanthine dehydrogenase/oxidase) at the PDBe-KB.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.